Evolus, Inc.
EOLS•NASDAQ•Healthcare•Drug Manufacturers - Specialty & Generic

About Evolus

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.evolus.com
Phone949 284 4555
Address
520 Newport Center Drive, Suite 1200 Newport Beach, California 92660 United States

Corporate Identifiers

CIK0001570562
CUSIP30052C107
ISINUS30052C1071
EIN46-1385614
SIC2834

Leadership Team & Key Executives

David Moatazedi
President, Chief Executive Officer and Director
Tomoko Yamagishi-Dressler
Chief Marketing Officer
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.
Chief Medical Officer and Head of Research and Development
Tatjana Mitchell
Chief Financial Officer
Nareg Sagherian
Head of Global Investor Relations and Corporate Communications
Jeffrey J. Plumer
General Counsel
Kurt Knab
Senior Vice President of Sales
Jessica Novak
Senior Vice President of Human Resources